Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Jeffrey Hung is an analyst at Morgan Stanley. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/12/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 07/12/2024 | PTCT | Buy Now | PTC Therapeutics | $33.30 | -3.9% | $30 → $32 | Maintains | Equal-Weight | Get Alert |
| 07/12/2024 | JAZZ | Buy Now | Jazz Pharmaceuticals | $103.33 | 45.17% | $160 → $150 | Maintains | Equal-Weight | Get Alert |
| 07/12/2024 | NBIX | Buy Now | Neurocrine Biosciences | $148.00 | 14.86% | $160 → $170 | Maintains | Overweight | Get Alert |
| 07/12/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $18.50 | 51.35% | $30 → $28 | Maintains | Overweight | Get Alert |
| 06/12/2024 | NBIX | Buy Now | Neurocrine Biosciences | $148.00 | 8.11% | $160 → $160 | Maintains | Overweight | Get Alert |
| 05/23/2024 | CRNX | Buy Now | Crinetics Pharmaceuticals | $54.28 | 28.96% | $50 → $70 | Maintains | Overweight | Get Alert |
| 05/10/2024 | FOLD | Buy Now | Amicus Therapeutics | $10.57 | 79.75% | $20 → $19 | Maintains | Overweight | Get Alert |
| 04/30/2024 | CTNM | Buy Now | Contineum Therapeutics | $21.00 | 19.05% | → $25 | Initiates | → Overweight | Get Alert |
| 04/29/2024 | PTCT | Buy Now | PTC Therapeutics | $33.30 | -9.91% | $28 → $30 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 04/02/2024 | IRON | Buy Now | Disc Medicine | $49.23 | -18.75% | $75 → $40 | Maintains | Equal-Weight | Get Alert |
| 03/13/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $18.50 | 62.16% | $40 → $30 | Maintains | Overweight | Get Alert |
| 03/08/2024 | ENGN | Buy Now | enGene Holdings | $9.20 | 334.78% | → $40 | Initiates | → Overweight | Get Alert |
| 02/20/2024 | CGON | Buy Now | CG Oncology | $36.66 | 50.03% | → $55 | Initiates | → Overweight | Get Alert |
| 01/16/2024 | CRNX | Buy Now | Crinetics Pharmaceuticals | $54.28 | -7.89% | → $50 | Initiates | → Overweight | Get Alert |
| 01/05/2024 | CYTK | Buy Now | Cytokinetics | $57.39 | 56.82% | $60 → $90 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 12/22/2023 | KRTX | Buy Now | Karuna Therapeutics | — | — | $295 → $330 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 12/19/2023 | PTCT | Buy Now | PTC Therapeutics | $33.30 | -15.92% | → $28 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 12/19/2023 | PRLD | Buy Now | Prelude Therapeutics | $5.80 | -31.03% | $10 → $4 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 12/19/2023 | VIGL | Buy Now | Vigil Neuroscience | $4.20 | -4.76% | $13 → $4 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 12/19/2023 | IRON | Buy Now | Disc Medicine | $49.23 | 32.03% | $56 → $65 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 12/19/2023 | RYTM | Buy Now | Rhythm Pharmaceuticals | $51.90 | 5.97% | $29 → $55 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 12/19/2023 | IVVD | Buy Now | Invivyd | $1.29 | 210.08% | $1 → $4 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 12/19/2023 | FOLD | Buy Now | Amicus Therapeutics | $10.57 | 89.21% | $15 → $20 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 12/19/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $18.50 | 116.22% | $31 → $40 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 12/08/2023 | BLUE | Buy Now | bluebird bio | $1.32 | 430.34% | $3 → $7 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 11/03/2023 | RARE | Buy Now | Ultragenyx Pharmaceutical | $44.46 | 88.93% | $90 → $84 | Maintains | Overweight | Get Alert |
| 11/03/2023 | BCYC | Buy Now | Bicycle Therapeutics | $22.60 | 76.99% | $42 → $40 | Maintains | Equal-Weight | Get Alert |
| 11/03/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $18.50 | 67.57% | $30 → $31 | Maintains | Equal-Weight | Get Alert |
| 10/27/2023 | PTCT | Buy Now | PTC Therapeutics | $33.30 | -15.92% | $31 → $28 | Maintains | Equal-Weight | Get Alert |
| 10/10/2023 | RARE | Buy Now | Ultragenyx Pharmaceutical | $44.46 | 102.43% | $95 → $90 | Maintains | Overweight | Get Alert |
| 10/10/2023 | RYTM | Buy Now | Rhythm Pharmaceuticals | $51.90 | -44.12% | $28 → $29 | Maintains | Equal-Weight | Get Alert |
| 09/18/2023 | PTCT | Buy Now | PTC Therapeutics | $33.30 | -6.91% | $47 → $31 | Maintains | Equal-Weight | Get Alert |
| 08/04/2023 | RARE | Buy Now | Ultragenyx Pharmaceutical | $44.46 | 113.68% | $95 → $95 | Reiterates | Overweight → Overweight | Get Alert |
| 08/04/2023 | PTCT | Buy Now | PTC Therapeutics | $33.30 | 41.14% | $47 → $47 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 08/04/2023 | PRLD | Buy Now | Prelude Therapeutics | $5.80 | 72.41% | $10 → $10 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 08/04/2023 | KRTX | Buy Now | Karuna Therapeutics | — | — | $280 → $280 | Reiterates | Overweight → Overweight | Get Alert |
| 08/04/2023 | ITCI | Buy Now | Intra-Cellular Therapies | $78.69 | 1.66% | $80 → $80 | Reiterates | Overweight → Overweight | Get Alert |
| 08/04/2023 | IMRX | Buy Now | Immuneering | $1.22 | 1047.54% | $14 → $14 | Maintains | Equal-Weight | Get Alert |
| 08/04/2023 | CYTK | Buy Now | Cytokinetics | $57.39 | 4.55% | $60 → $60 | Reiterates | Overweight → Overweight | Get Alert |
| 08/04/2023 | BCYC | Buy Now | Bicycle Therapeutics | $22.60 | 85.84% | $42 → $42 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 08/03/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $18.50 | 62.16% | $30 → $30 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 08/02/2023 | RYTM | Buy Now | Rhythm Pharmaceuticals | $51.90 | -46.05% | $28 → $28 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 08/02/2023 | NBIX | Buy Now | Neurocrine Biosciences | $148.00 | -12.16% | $130 → $130 | Reiterates | Overweight → Overweight | Get Alert |
| 07/20/2023 | KRTX | Buy Now | Karuna Therapeutics | — | — | → $280 | Initiates | → Overweight | Get Alert |
| 07/14/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $18.50 | 62.16% | $21 → $30 | Maintains | Equal-Weight | Get Alert |
| 07/11/2023 | ADCT | Buy Now | ADC Therapeutics | $4.09 | -51.1% | $5 → $5 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/11/2023 | PTCT | Buy Now | PTC Therapeutics | $33.30 | 41.14% | $50 → $47 | Maintains | Equal-Weight | Get Alert |
| 07/11/2023 | NBIX | Buy Now | Neurocrine Biosciences | $148.00 | -12.16% | $130 → $130 | Reiterates | Overweight → Overweight | Get Alert |
| 07/11/2023 | JAZZ | Buy Now | Jazz Pharmaceuticals | $103.33 | 80.97% | $187 → $187 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/11/2023 | ITCI | Buy Now | Intra-Cellular Therapies | $78.69 | 1.66% | $80 → $80 | Reiterates | Overweight → Overweight | Get Alert |
| 07/11/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $18.50 | 13.51% | $20 → $21 | Maintains | Equal-Weight | Get Alert |
| 06/22/2023 | CYTK | Buy Now | Cytokinetics | $57.39 | 4.55% | → $60 | Reiterates | → Overweight | Get Alert |
| 06/12/2023 | IRON | Buy Now | Disc Medicine | $49.23 | 13.75% | $37 → $56 | Maintains | Overweight | Get Alert |
| 04/21/2023 | ITCI | Buy Now | Intra-Cellular Therapies | $78.69 | 1.66% | → $80 | Reiterates | → Overweight | Get Alert |
| 04/21/2023 | IRON | Buy Now | Disc Medicine | $49.23 | -24.84% | → $37 | Reiterates | → Overweight | Get Alert |
| 04/20/2023 | IRON | Buy Now | Disc Medicine | $49.23 | -24.84% | → $37 | Initiates | → Overweight | Get Alert |
| 04/20/2023 | ITCI | Buy Now | Intra-Cellular Therapies | $78.69 | 1.66% | → $80 | Initiates | → Overweight | Get Alert |
| 04/19/2023 | IMRX | Buy Now | Immuneering | $1.22 | 1047.54% | $5 → $14 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 03/20/2023 | ESPR | Buy Now | Esperion Therapeutics | $2.49 | 20.48% | $9 → $3 | Maintains | Equal-Weight | Get Alert |
| 03/14/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $18.50 | 8.11% | $19 → $20 | Maintains | Equal-Weight | Get Alert |
| 03/02/2023 | RYTM | Buy Now | Rhythm Pharmaceuticals | $51.90 | -46.05% | $26 → $28 | Maintains | Equal-Weight | Get Alert |
| 02/28/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $18.50 | 2.7% | $18 → $19 | Maintains | Equal-Weight | Get Alert |
| 02/27/2023 | RPTX | Buy Now | Repare Therapeutics | $3.61 | 287.81% | $15 → $14 | Maintains | Equal-Weight | Get Alert |
| 02/03/2023 | RARE | Buy Now | Ultragenyx Pharmaceutical | $44.46 | 113.68% | $100 → $95 | Maintains | Overweight | Get Alert |
| 02/03/2023 | PTCT | Buy Now | PTC Therapeutics | $33.30 | 50.15% | $40 → $50 | Maintains | Equal-Weight | Get Alert |
| 02/03/2023 | GRPH | Buy Now | Graphite Bio | — | — | $42 → $21 | Maintains | Equal-Weight | Get Alert |
| 02/03/2023 | CGEM | Buy Now | Cullinan Oncology | $16.59 | 14.53% | $27 → $19 | Maintains | Overweight | Get Alert |
| 02/03/2023 | RPTX | Buy Now | Repare Therapeutics | $3.61 | 315.51% | $28 → $15 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 02/03/2023 | NBIX | Buy Now | Neurocrine Biosciences | $148.00 | -12.16% | $120 → $130 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 02/03/2023 | IMRX | Buy Now | Immuneering | $1.22 | 309.84% | $12 → $5 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 02/03/2023 | ESPR | Buy Now | Esperion Therapeutics | $2.49 | 261.45% | → $9 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 02/03/2023 | ERAS | Buy Now | Erasca | $2.93 | 411.95% | → $15 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 02/03/2023 | CYT | Buy Now | Cyteir Therapeutics | — | — | $4 → $2 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 01/30/2023 | CELU | Buy Now | Celularity | $3.03 | -67% | $50 → $10 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 01/10/2023 | CINC | Buy Now | CinCor Pharma | — | — | $22 → $30 | Maintains | Equal-Weight | Get Alert |
| 11/29/2022 | CINC | Buy Now | CinCor Pharma | — | — | $60 → $22 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 11/15/2022 | PRLD | Buy Now | Prelude Therapeutics | $5.80 | 72.41% | $11 → $10 | Maintains | Equal-Weight | Get Alert |
| 11/09/2022 | RYTM | Buy Now | Rhythm Pharmaceuticals | $51.90 | -49.9% | $16 → $26 | Maintains | Equal-Weight | Get Alert |
| 11/03/2022 | RARE | Buy Now | Ultragenyx Pharmaceutical | $44.46 | 124.92% | $109 → $100 | Maintains | Overweight | Get Alert |
| 11/02/2022 | NBIX | Buy Now | Neurocrine Biosciences | $148.00 | -18.92% | $102 → $120 | Maintains | Equal-Weight | Get Alert |
| 11/02/2022 | EXEL | Buy Now | Exelixis | $22.55 | -2.44% | $23 → $22 | Maintains | Equal-Weight | Get Alert |
| 11/02/2022 | ESPR | Buy Now | Esperion Therapeutics | $2.49 | 261.45% | $7 → $9 | Maintains | Underweight | Get Alert |
| 09/12/2022 | CELU | Buy Now | Celularity | $3.03 | 65.02% | $80 → $50 | Maintains | Equal-Weight | Get Alert |
| 09/12/2022 | BCYC | Buy Now | Bicycle Therapeutics | $22.60 | 99.12% | $60 → $45 | Maintains | Equal-Weight | Get Alert |
| 09/09/2022 | RUBY | Buy Now | Rubius Therapeutics | $0.06 | 2531.58% | $2 → $1.5 | Maintains | Equal-Weight | Get Alert |
| 09/09/2022 | CINC | Buy Now | CinCor Pharma | — | — | $45 → $60 | Maintains | Overweight | Get Alert |
| 09/09/2022 | PRLD | Buy Now | Prelude Therapeutics | $5.80 | 89.66% | $19 → $11 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 09/09/2022 | CYT | Buy Now | Cyteir Therapeutics | — | — | $14 → $4 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 08/09/2022 | CINC | Buy Now | CinCor Pharma | — | — | $31 → $45 | Maintains | Overweight | Get Alert |
| 08/09/2022 | ACAD | Buy Now | ACADIA Pharmaceuticals | $18.50 | -2.7% | $22 → $18 | Maintains | Equal-Weight | Get Alert |
| 08/08/2022 | RPTX | Buy Now | Repare Therapeutics | $3.61 | 675.62% | $30 → $28 | Maintains | Overweight | Get Alert |
| 08/04/2022 | JAZZ | Buy Now | Jazz Pharmaceuticals | $103.33 | 80.97% | $174 → $187 | Maintains | Equal-Weight | Get Alert |
| 08/03/2022 | RYTM | Buy Now | Rhythm Pharmaceuticals | $51.90 | -69.17% | $8 → $16 | Maintains | Equal-Weight | Get Alert |
| 07/15/2022 | EXEL | Buy Now | Exelixis | $22.55 | 2% | $22 → $23 | Maintains | Equal-Weight | Get Alert |
| 07/15/2022 | RYTM | Buy Now | Rhythm Pharmaceuticals | $51.90 | -84.59% | $4 → $8 | Maintains | Equal-Weight | Get Alert |
| 07/15/2022 | NBIX | Buy Now | Neurocrine Biosciences | $148.00 | -31.08% | $100 → $102 | Maintains | Equal-Weight | Get Alert |
| 07/15/2022 | GRPH | Buy Now | Graphite Bio | — | — | $56 → $42 | Maintains | Equal-Weight | Get Alert |
| 07/15/2022 | EVFM | Buy Now | Evofem Biosciences | $0.01 | 7794.74% | $250 → $93.75 | Maintains | Underweight | Get Alert |
| 07/15/2022 | ESPR | Buy Now | Esperion Therapeutics | $2.49 | 181.12% | $5 → $7 | Maintains | Underweight | Get Alert |
| 07/15/2022 | CYTK | Buy Now | Cytokinetics | $57.39 | 4.55% | $46 → $60 | Maintains | Overweight | Get Alert |
| 07/15/2022 | CINC | Buy Now | CinCor Pharma | — | — | $27 → $31 | Maintains | Overweight | Get Alert |
| 07/15/2022 | ACAD | Buy Now | ACADIA Pharmaceuticals | $18.50 | 18.92% | $24 → $22 | Maintains | Equal-Weight | Get Alert |
| 06/07/2022 | RYTM | Buy Now | Rhythm Pharmaceuticals | $51.90 | -92.29% | $12 → $4 | Maintains | Equal-Weight | Get Alert |
| 05/11/2022 | RUBY | Buy Now | Rubius Therapeutics | $0.06 | 3408.77% | $4 → $2 | Maintains | Equal-Weight | Get Alert |
| 05/11/2022 | EVFM | Buy Now | Evofem Biosciences | $0.01 | 20952.63% | $1068.75 → $250 | Maintains | Underweight | Get Alert |
| 05/11/2022 | BHVN | Buy Now | Biohaven | $38.45 | 286.22% | $146 → $148.5 | Maintains | Equal-Weight | Get Alert |
| 05/10/2022 | EVFM | Buy Now | Evofem Biosciences | $0.01 | 89900% | $71.25 → $1068.75 | Maintains | Underweight | Get Alert |
| 05/06/2022 | RARE | Buy Now | Ultragenyx Pharmaceutical | $44.46 | 145.16% | $118 → $109 | Maintains | Overweight | Get Alert |
| 04/12/2022 | EVFM | Buy Now | Evofem Biosciences | $0.01 | 5900% | $7.95 → $8.55 | Maintains | Underweight | Get Alert |
| 04/11/2022 | RUBY | Buy Now | Rubius Therapeutics | $0.06 | 6917.54% | $15 → $4 | Maintains | Equal-Weight | Get Alert |
| 04/06/2022 | BHVN | Buy Now | Biohaven | $38.45 | 279.71% | $148 → $146 | Maintains | Equal-Weight | Get Alert |
| 03/22/2022 | GRPH | Buy Now | Graphite Bio | — | — | $133 → $56 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 03/17/2022 | PRLD | Buy Now | Prelude Therapeutics | $5.80 | 227.59% | $20 → $19 | Maintains | Overweight | Get Alert |
| 03/04/2022 | EVFM | Buy Now | Evofem Biosciences | $0.01 | 5478.95% | $7.5 → $7.95 | Maintains | Underweight | Get Alert |
| 02/14/2022 | NBIX | Buy Now | Neurocrine Biosciences | $148.00 | -32.43% | $95 → $100 | Maintains | Equal-Weight | Get Alert |
| 02/14/2022 | BCYC | Buy Now | Bicycle Therapeutics | $22.60 | 165.49% | → $60 | Initiates | → Equal-Weight | Get Alert |
| 02/11/2022 | RARE | Buy Now | Ultragenyx Pharmaceutical | $44.46 | 165.41% | $120 → $118 | Maintains | Overweight | Get Alert |
| 02/01/2022 | NBIX | Buy Now | Neurocrine Biosciences | $148.00 | -35.81% | $103 → $95 | Maintains | Equal-Weight | Get Alert |
| 02/01/2022 | CINC | Buy Now | CinCor Pharma | — | — | → $27 | Initiates | → Overweight | Get Alert |
| 01/07/2022 | NBIX | Buy Now | Neurocrine Biosciences | $148.00 | -30.41% | $112 → $103 | Maintains | Equal-Weight | Get Alert |
| 12/07/2021 | ACAD | Buy Now | ACADIA Pharmaceuticals | $18.50 | 29.73% | — | Maintains | Equal-Weight | Get Alert |
| 11/24/2021 | CELU | Buy Now | Celularity | $3.03 | 197.03% | → $90 | Initiates | → Equal-Weight | Get Alert |
| 11/19/2021 | RYTM | Buy Now | Rhythm Pharmaceuticals | $51.90 | -71.1% | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 07/20/2021 | GRPH | Buy Now | Graphite Bio | — | — | → $245 | Initiates | → Overweight | Get Alert |
